산업용 미생물 검사 시장 : 제품 유형, 검사 유형, 용도별 - 세계 예측(2025-2030년)

The Industrial Microbiology Market was valued at USD 17.06 billion in 2023, expected to reach USD 18.41 billion in 2024, and is projected to grow at a CAGR of 8.11%, to USD 29.46 billion by 2030.

Industrial microbiology is a field that employs microorganisms to produce, process, or synthesize products on a large scale. This scope encompasses diverse sectors like pharmaceuticals, food and beverages, agriculture, and biofuels, where microbial technology plays a crucial role in enhancing production efficiency and product quality. The necessity of industrial microbiology rests in its ability to optimize bioprocesses, improve yield, and create sustainable solutions across industries. Applications are vast, including fermentation processes, strain improvement, and production of bio-based chemicals, antibiotics, and enzymes. The end-use scope is similarly extensive, covering manufacturers in healthcare, agriculture, and renewable energy sectors seeking cost-effective biotechnological solutions. Market insights reveal that growth is primarily driven by rising demand for microbial-produced goods, eco-friendly products, and the need for agricultural innovations. Advances in genetic engineering, bioprocess optimization, and the increasing adoption of industrial microbiology in developing economies present significant opportunities. To capitalize on these, companies should invest in R&D for innovative bioproducts and scalable microbial processes, leveraging advancements in synthetic biology and precision fermentation technologies. However, limitations such as high initial investment costs, regulatory hurdles, and the complexity of scale-up processes pose challenges. Moreover, the market is constrained by the need for skilled professionals and potential public perception issues regarding genetically modified organisms (GMOs). Areas ripe for innovation include CRISPR technology for microbial strain engineering, bioinformatics for microbiome analytics, and developing resilient microbial strains for adverse conditions. Companies could also explore partnerships with academic institutions to drive technological advancements. The market operates in a dynamic, innovation-driven environment, and businesses that stay agile in harnessing cutting-edge techniques will likely remain competitive, tapping into emerging biotechnologies to fuel sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Industrial Microbiology Market

The Industrial Microbiology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing production of antibiotics, drug products, and natural cosmetic ingredients
  • Rising concerns about waste management and government initiatives for renewable energy
  • Increasing consumer preference for novel and nutritionally rich food and beverage options
• Market Restraints
  • Chances of contamination and the need for precise control of environmental parameters
• Market Opportunities
  • Advancements and research initiatives to optimize industrial microbiology processes
  • Inclination towards adoption of precision agriculture for efficient crop production
• Market Challenges
  • Limitations of machinery and process handling of industrial microbiology and lack of skilled personnel

Porter's Five Forces: A Strategic Tool for Navigating the Industrial Microbiology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Industrial Microbiology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Industrial Microbiology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Industrial Microbiology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Industrial Microbiology Market

A detailed market share analysis in the Industrial Microbiology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Industrial Microbiology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Industrial Microbiology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Industrial Microbiology Market, highlighting leading vendors and their innovative profiles. These include Eppendorf SE, Danaher Corporation, Vermicon AG, Bruker Corporation, SSI Diagnostica A/S, Corning Incorporated, Novamed, Ltd. by Simplivia Healthcare Ltd., Thermo Fisher Scientific Inc., Sartorius AG, Cysal GmbH, Charles River Laboratories International, Inc., Microbe Investigations AG, Solenis LLC, HiMedia Laboratories Private Limited, HyLabs Ltd., Reshape ApS, Merck KGaA, Asiagel Corporation, Condalab, Becton, Dickinson and Company, Fujifilm Holdings Corporation, bNovate Technologies SA, Sporian Microsystems Inc., Qiagen N. V., Agilent Technologies, Inc., Sysmex Corporation, 3M Company, BioMerieux SA, ELITechGroup Inc., and Bio-Rad Laboratories, Inc..

Market Segmentation & Coverage

This research report categorizes the Industrial Microbiology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Consumables, Equipment & Systems, and Laboratory Supplies. The Consumables is further studied across Media and Reagents & Strains. The Equipment & Systems is further studied across Air Monitoring Systems, Automated Equipment, Filtration Pumps & Systems, Incubators & Culture Apparatus, and Microbial Detection Systems. The Laboratory Supplies is further studied across Bags & Bottles, Filtration Disc & Membranes, Loop & Needles, and Petri Dishes, Racks, Seals, Plates & Holders.
• Based on Test Type, market is studied across Bio-Burden Testing, Microbial Limits Testing, Sterility Testing, and Water & Environmental Testing.
• Based on Application, market is studied across Agricultural, Cosmetic or Personal Care, Environmental, Food & Beverage, Pharmaceutical & Biotechnology, and Wastewater & Sewage Treatment.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing production of antibiotics, drug products, and natural cosmetic ingredients
    • 5.1.1.2. Rising concerns about waste management and government initiatives for renewable energy
    • 5.1.1.3. Increasing consumer preference for novel and nutritionally rich food and beverage options
  • 5.1.2. Restraints
    • 5.1.2.1. Chances of contamination and the need for precise control of environmental parameters
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements and research initiatives to optimize industrial microbiology processes
    • 5.1.3.2. Inclination towards adoption of precision agriculture for efficient crop production
  • 5.1.4. Challenges
    • 5.1.4.1. Limitations of machinery and process handling of industrial microbiology and lack of skilled personnel
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Development of advanced equipment for streamlining industrial microbiology processes
  • 5.2.2. Test Type: Utilization of microbial limits testing to ensure sterility of pharmaceutical and medical products
  • 5.2.3. Application: Growing sustainability and waste management concerns driving the utilization of industrial microbiology in the environmental industry
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Industrial Microbiology Market, by Product Type

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Media
  • 6.2.2. Reagents & Strains
• 6.3. Equipment & Systems
  • 6.3.1. Air Monitoring Systems
  • 6.3.2. Automated Equipment
  • 6.3.3. Filtration Pumps & Systems
  • 6.3.4. Incubators & Culture Apparatus
  • 6.3.5. Microbial Detection Systems
• 6.4. Laboratory Supplies
  • 6.4.1. Bags & Bottles
  • 6.4.2. Filtration Disc & Membranes
  • 6.4.3. Loop & Needles
  • 6.4.4. Petri Dishes, Racks, Seals, Plates & Holders

7. Industrial Microbiology Market, by Test Type

• 7.1. Introduction
• 7.2. Bio-Burden Testing
• 7.3. Microbial Limits Testing
• 7.4. Sterility Testing
• 7.5. Water & Environmental Testing

8. Industrial Microbiology Market, by Application

• 8.1. Introduction
• 8.2. Agricultural
• 8.3. Cosmetic or Personal Care
• 8.4. Environmental
• 8.5. Food & Beverage
• 8.6. Pharmaceutical & Biotechnology
• 8.7. Wastewater & Sewage Treatment

9. Americas Industrial Microbiology Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Industrial Microbiology Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Industrial Microbiology Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. QIAGEN Launches Complete Sample to Insight Workflow for Microbiome Research
  • 12.3.2. New Acquisition to Accelerate Microbiome Therapeutics Manufacture
  • 12.3.3. Eppendorf Introduces the First Microcentrifuge with Hydrocarbon Cooling
  • 12.3.4. bNovate Technologies Raises USD 13.4 Million(~CHF 12 million)
  • 12.3.5. Solvay Announces Plans to Build a Multipurpose Microbiology Lab in Europe
  • 12.3.6. Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID
  • 12.3.7. Visolis and Ginkgo Bioworks Announce Partnership to Improve Microbial Strain for Bio-Isoprene and Sustainable Aviation Fuel Production
  • 12.3.8. Sysmex to Establish New Manufacturing Base in India - Creating a manufacturing structure in India to Support Sustainable Growth
  • 12.3.9. Sartorius Stedim Biotech to Acquire Polyplus
  • 12.3.10. InDevR Partners with bioMerieux
  • 12.3.11. BD Launches Third-GenerationTotal Lab Automation System
  • 12.3.12. 3M Invests USD 146M in Biopharma Filtration Technology

Companies Mentioned

• 1. Eppendorf SE
• 2. Danaher Corporation
• 3. Vermicon AG
• 4. Bruker Corporation
• 5. SSI Diagnostica A/S
• 6. Corning Incorporated
• 7. Novamed, Ltd. by Simplivia Healthcare Ltd.
• 8. Thermo Fisher Scientific Inc.
• 9. Sartorius AG
• 10. Cysal GmbH
• 11. Charles River Laboratories International, Inc.
• 12. Microbe Investigations AG
• 13. Solenis LLC
• 14. HiMedia Laboratories Private Limited
• 15. HyLabs Ltd.
• 16. Reshape ApS
• 17. Merck KGaA
• 18. Asiagel Corporation
• 19. Condalab
• 20. Becton, Dickinson and Company
• 21. Fujifilm Holdings Corporation
• 22. bNovate Technologies SA
• 23. Sporian Microsystems Inc.
• 24. Qiagen N. V.
• 25. Agilent Technologies, Inc.
• 26. Sysmex Corporation
• 27. 3M Company
• 28. BioMerieux SA
• 29. ELITechGroup Inc.
• 30. Bio-Rad Laboratories, Inc.